Mckenzie Esther Sorrell, DO | |
11110 Medical Campus Rd Ste 130, Hagerstown, MD 21742-6799 | |
(301) 665-4710 | |
Not Available |
Full Name | Mckenzie Esther Sorrell |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 7 Years |
Location | 11110 Medical Campus Rd Ste 130, Hagerstown, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184144529 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | LL40720 (South Carolina) | Secondary |
207R00000X | Internal Medicine | H97063 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hospice Of Washington County, Inc | Hagerstown, MD | Hospice |
Meritus Medical Center | Hagerstown, MD | Hospital |
Waynesboro Hospital | Waynesboro, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medical Practices Of Antietam, Llc | 2567353865 | 184 |
News Archive
Corning Incorporated today announced the Corning Lab for the Cure™ program, a first-of-its-kind corporate sponsorship agreement with Susan G. Komen for the Cure®.
A team of international researchers has found that the Tsimane indigenous people of the Bolivian Amazon experience less brain atrophy than their American and European peers.
The first-ever national, regional, and global estimates of preterm birth reveals that 15 million babies are born too soon every year and 1.1 million of those babies die shortly after birth, making premature birth the second-leading cause of death in children under age 5.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer.
Remarkable new tools that spotlight individual cellular molecules are transforming biomedical research.
› Verified 2 days ago
Entity Name | Medical Practices Of Antietam, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558430843 PECOS PAC ID: 2567353865 Enrollment ID: O20040324001019 |
News Archive
Corning Incorporated today announced the Corning Lab for the Cure™ program, a first-of-its-kind corporate sponsorship agreement with Susan G. Komen for the Cure®.
A team of international researchers has found that the Tsimane indigenous people of the Bolivian Amazon experience less brain atrophy than their American and European peers.
The first-ever national, regional, and global estimates of preterm birth reveals that 15 million babies are born too soon every year and 1.1 million of those babies die shortly after birth, making premature birth the second-leading cause of death in children under age 5.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer.
Remarkable new tools that spotlight individual cellular molecules are transforming biomedical research.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mckenzie Esther Sorrell, DO 11110 Medical Campus Rd Ste 130, Hagerstown, MD 21742-6799 Ph: () - | Mckenzie Esther Sorrell, DO 11110 Medical Campus Rd Ste 130, Hagerstown, MD 21742-6799 Ph: (301) 665-4710 |
News Archive
Corning Incorporated today announced the Corning Lab for the Cure™ program, a first-of-its-kind corporate sponsorship agreement with Susan G. Komen for the Cure®.
A team of international researchers has found that the Tsimane indigenous people of the Bolivian Amazon experience less brain atrophy than their American and European peers.
The first-ever national, regional, and global estimates of preterm birth reveals that 15 million babies are born too soon every year and 1.1 million of those babies die shortly after birth, making premature birth the second-leading cause of death in children under age 5.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer.
Remarkable new tools that spotlight individual cellular molecules are transforming biomedical research.
› Verified 2 days ago
Sadik Mohammed Ali, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 251 E Antietam St, Hagerstown, MD 21740 Phone: 301-790-8804 | |
Dr. Alida Mercedes Espinoza, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1130 Opal Ct, Hagerstown, MD 21740 Phone: 301-797-8279 Fax: 301-797-8504 | |
Dr. James E Cremins, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11110 Medical Campus Rd, Suite 242, Hagerstown, MD 21742 Phone: 240-382-3783 Fax: 240-382-3799 | |
Jason Slack, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11116 Medical Campus Rd, Hagerstown, MD 21742 Phone: 301-790-8804 | |
Fahad Lodhi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1733 Howell Rd, Hagerstown, MD 21740 Phone: 301-797-2525 | |
Dr. Tarek Nabil El-sherif, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11110 Medical Campus Rd, # 223, Hagerstown, MD 21742 Phone: 301-560-4747 Fax: 301-776-1725 | |
Khetisuda Suvarnasuddhi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Ave, Hagerstown, MD 21742 Phone: 301-797-9600 Fax: 301-797-3854 |